Characterization of inhibitor binding to human kinesin spindle protein by site-directed mutagenesis
- PMID: 19467625
- DOI: 10.1016/j.abb.2009.01.015
Characterization of inhibitor binding to human kinesin spindle protein by site-directed mutagenesis
Abstract
A number of inhibitors of kinesin spindle protein (KSP) have been described, which are known from X-ray crystallography studies to bind to an induced fit pocket defined by the L5 loop. We describe the characterization of eight mutant forms of KSP in which six residues that line this pocket have been altered. Mutants were analyzed by measuring rates of enzyme catalysis, in the presence and absence of six KSP inhibitors of four diverse structural classes and of varied ATP-competition status. Our analysis was in agreement with the model of binding established by the structural studies and suggests that binding energy is well distributed across functional groups in these molecules. The majority of the mutants retained significant enzymatic activity while diminishing inhibitor binding, indicating potential for the development of drug resistance. These data provide detailed information on interactions between inhibitor and binding pocket at the functional group level and enable the development of novel KSP inhibitors.
Similar articles
-
Discovery and biochemical characterization of selective ATP competitive inhibitors of the human mitotic kinesin KSP.Arch Biochem Biophys. 2008 Jan 15;469(2):220-31. doi: 10.1016/j.abb.2007.10.016. Epub 2007 Nov 1. Arch Biochem Biophys. 2008. PMID: 17999913
-
Thermodynamics of nucleotide and inhibitor binding to wild-type and ispinesib-resistant forms of human kinesin spindle protein.Biochemistry. 2009 Nov 24;48(46):11045-55. doi: 10.1021/bi900946r. Biochemistry. 2009. PMID: 19824700
-
Kinesin spindle protein inhibitors in cancer: a patent review (2008 - present).Expert Opin Ther Pat. 2013 Dec;23(12):1547-60. doi: 10.1517/13543776.2013.833606. Epub 2013 Aug 26. Expert Opin Ther Pat. 2013. PMID: 23978071 Review.
-
Structural basis of new allosteric inhibition in Kinesin spindle protein Eg5.ACS Chem Biol. 2015 Apr 17;10(4):1128-36. doi: 10.1021/cb500939x. Epub 2015 Feb 3. ACS Chem Biol. 2015. PMID: 25622007
-
Recent progress in the identification and clinical evaluation of inhibitors of the mitotic kinesin KSP.Curr Top Med Chem. 2008;8(10):888-904. doi: 10.2174/156802608784911626. Curr Top Med Chem. 2008. PMID: 18673173 Review.
Cited by
-
Loop 5-directed compounds inhibit chimeric kinesin-5 motors: implications for conserved allosteric mechanisms.J Biol Chem. 2011 Feb 25;286(8):6201-10. doi: 10.1074/jbc.M110.154989. Epub 2010 Dec 2. J Biol Chem. 2011. PMID: 21127071 Free PMC article.
-
Synthesis and characterization of tritylthioethanamine derivatives with potent KSP inhibitory activity.Bioorg Med Chem. 2011 Sep 15;19(18):5446-53. doi: 10.1016/j.bmc.2011.07.054. Epub 2011 Jul 30. Bioorg Med Chem. 2011. PMID: 21855351 Free PMC article.
-
Kinesin spindle protein inhibitors in cancer: from high throughput screening to novel therapeutic strategies.Future Sci OA. 2022 Feb 21;8(3):FSO778. doi: 10.2144/fsoa-2021-0116. eCollection 2022 Mar. Future Sci OA. 2022. PMID: 35251692 Free PMC article. Review.
-
Allosteric drug discrimination is coupled to mechanochemical changes in the kinesin-5 motor core.J Biol Chem. 2010 Jun 11;285(24):18650-61. doi: 10.1074/jbc.M109.092072. Epub 2010 Mar 18. J Biol Chem. 2010. PMID: 20299460 Free PMC article.
-
Drug resistance dependent on allostery: A P-loop rigor Eg5 mutant exhibits resistance to allosteric inhibition by STLC.Front Oncol. 2022 Oct 12;12:965455. doi: 10.3389/fonc.2022.965455. eCollection 2022. Front Oncol. 2022. PMID: 36313676 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources